Mead Johnson Nutrition Co. (NYSE:MJN) received a $95.00 price objective from Credit Suisse Group AG in a research note issued to investors on Wednesday. The firm currently has a a “buy” rating on the stock. Credit Suisse Group AG’s price objective would indicate a potential upside of 18.47% from the stock’s current price.

A number of other brokerages have also issued reports on MJN. Susquehanna reaffirmed a “hold” rating on shares of Mead Johnson Nutrition in a research note on Thursday, June 16th. Bank of America Corp. raised Mead Johnson Nutrition from an “underperform” rating to a “neutral” rating and set a $93.00 price target for the company in a research note on Wednesday, July 13th. Goldman Sachs Group Inc. reaffirmed a “neutral” rating and set a $96.00 price target (up from $91.00) on shares of Mead Johnson Nutrition in a research note on Friday, July 15th. Citigroup Inc. increased their price target on Mead Johnson Nutrition from $100.00 to $105.00 and gave the company a “buy” rating in a research note on Monday, July 25th. Finally, Deutsche Bank AG set a $88.00 price target on Mead Johnson Nutrition and gave the company a “hold” rating in a research note on Sunday, July 24th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and six have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $94.33.

Analyst Recommendations for Mead Johnson Nutrition (NYSE:MJN)

Shares of Mead Johnson Nutrition (NYSE:MJN) traded up 0.77% during midday trading on Wednesday, hitting $80.81. The stock had a trading volume of 915,088 shares. Mead Johnson Nutrition has a 12-month low of $65.53 and a 12-month high of $94.40. The company’s 50-day moving average price is $79.94 and its 200-day moving average price is $84.66. The firm has a market cap of $14.92 billion, a price-to-earnings ratio of 30.40 and a beta of 1.26.

Mead Johnson Nutrition (NYSE:MJN) last issued its quarterly earnings data on Thursday, July 28th. The company reported $0.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.78 by $0.10. Mead Johnson Nutrition had a negative return on equity of 194.30% and a net margin of 13.28%. The business earned $941.50 million during the quarter, compared to analyst estimates of $967.25 million. During the same period in the prior year, the company posted $0.76 EPS. The business’s revenue for the quarter was down 8.8% compared to the same quarter last year. Equities research analysts forecast that Mead Johnson Nutrition will post $3.48 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Monday, October 3rd. Investors of record on Monday, September 19th were issued a dividend of $0.4125 per share. The ex-dividend date was Thursday, September 15th. This represents a $1.65 annualized dividend and a dividend yield of 2.06%. Mead Johnson Nutrition’s dividend payout ratio is 62.03%.

In related news, Director Kimberly A. Casiano sold 710 shares of the stock in a transaction on Monday, August 15th. The stock was sold at an average price of $89.75, for a total transaction of $63,722.50. Following the completion of the sale, the director now directly owns 7,110 shares in the company, valued at $638,122.50. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Graciela Monteagudo sold 45,873 shares of the stock in a transaction on Friday, August 5th. The stock was sold at an average price of $87.64, for a total value of $4,020,309.72. Following the sale, the senior vice president now owns 13,800 shares of the company’s stock, valued at $1,209,432. The disclosure for this sale can be found here. Corporate insiders own 0.50% of the company’s stock.

Several hedge funds have recently made changes to their positions in the company. Northwestern Mutual Wealth Management Co. raised its stake in shares of Mead Johnson Nutrition by 11.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,287 shares of the company’s stock valued at $118,000 after buying an additional 131 shares in the last quarter. Pinkerton Retirement Specialists LLC purchased a new stake in shares of Mead Johnson Nutrition during the second quarter valued at about $128,000. Checchi Capital Advisers LLC raised its stake in shares of Mead Johnson Nutrition by 2.5% in the second quarter. Checchi Capital Advisers LLC now owns 1,418 shares of the company’s stock valued at $129,000 after buying an additional 35 shares in the last quarter. Feltz Wealth PLAN Inc. purchased a new stake in shares of Mead Johnson Nutrition during the second quarter valued at about $180,000. Finally, MSI Financial Services Inc raised its stake in shares of Mead Johnson Nutrition by 13.7% in the third quarter. MSI Financial Services Inc now owns 2,632 shares of the company’s stock valued at $208,000 after buying an additional 318 shares in the last quarter. Institutional investors and hedge funds own 96.93% of the company’s stock.

About Mead Johnson Nutrition

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.

5 Day Chart for NYSE:MJN

Receive News & Stock Ratings for Mead Johnson Nutrition Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition Co. and related stocks with our FREE daily email newsletter.